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Abstract
Background: Three randomised controlled trials have clearly shown that circumcision of adult men reduces the chance that
they acquire HIV infection. However, the potential impact of circumcision programmes – either alone or in combination
with other established approaches – is not known and no further field trials are planned. We have used a mathematical
model, parameterised using existing trial findings, to understand and predict the impact of circumcision programmes at the
population level.
Findings: Our results indicate that circumcision will lead to reductions in incidence for women and uncircumcised men, as
well as those circumcised, but that even the most effective intervention is unlikely to completely stem the spread of the
virus. Without additional interventions, HIV incidence could eventually be reduced by 25–35%, depending on the level of
coverage achieved and whether onward transmission from circumcised men is also reduced. However, circumcision
interventions can act synergistically with other types of prevention programmes, and if efforts to change behaviour are
increased in parallel with the scale-up of circumcision services, then dramatic reductions in HIV incidence could be achieved.
In the long-term, this could lead to reduced AIDS deaths and less need for anti-retroviral therapy. Any increases in risk
behaviours following circumcision , i.e. ‘risk compensation’, could offset some of the potential benefit of the intervention,
especially for women, but only very large increases would lead to more infections overall.
Conclusions: Circumcision will not be the silver bullet to prevent HIV transmission, but interventions could help to
substantially protect men and women from infection, especially in combination with other approaches.
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Introduction
In response to improved surveillance data, the Joint United
Nations Agency on AIDS (UNAIDS) has recently revised official
estimates of the numbers living with HIV worldwide [1]. These
figures show that HIV prevalence in Africa probably peaked in the
late 1990s. However, in most countries this is due to an increase in
AIDS deaths coinciding with the epidemic predominantly moving
to lower risk individuals [2,3,4,5,6]. It has been suggested that a
significant corner has been turned in the fight against the HIV
epidemic [7], but an incidence rate where 2.8 million men, women
and children newly infected each year in sub-Saharan Africa is
unacceptable [1]. Our failure to reduce incidence more substan-
tially requires a re-examination of what interventions, singly or in
combination, are best suited to reverse the HIV pandemic.
Significant scientific advances have been made in understanding
how heterosexual transmission can be limited. First, the potential
impact of behaviour change was indicated in Uganda [4], and
later Zimbabwe [8]. Trials in the 1990s showed that, whilst useful
early on, improved bacterial STI management is unlikely to
substantially reduce HIV incidence in mature HIV epidemics
[9,10,11,12,13,14]. In the last year, a population level behaviour
change intervention was found to be ineffective [15] and risk
compensation and low adherence may have contributed to no
effect being found in trials to prevent HIV infection through
diaphragm use [16] and herpes treatment [17], respectively. This
tally adds to over 30 randomized clinical trials that failed to show
efficacy or effectiveness in reducing HIV incidence [18]. However,
three recent randomised controlled trials of adult male circumci-
sion uniformly found that circumcised men are 60% less likely to
be infected than others [19,20,21]. The World Health Organiza-
tion (WHO) and UNAIDS have recommend that circumcision be
considered as part of intervention programmes in high-prevalence
settings [22,23].
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interventions at the individual-level [24], they do not provide
information on how incidence might be reduced across popula-
tions, which is the primary concern in public health [25,26]. No
further trials are planned, so in this article, we have used existing
data from trials and field studies in a mathematical model to help
address some of the most pressing questions surrounding male
circumcision. This should help ground planning and decision-
making in an evidence-based framework [27,28]. The program-
matic issues which we have addressed are:
1. What is the likely net impact of circumcision interventions?
2. How will circumcision interventions interact with existing
interventions?
3. Is there the potential for perverse impacts on HIV spread from
scale up of circumcision?
Methods
A simple deterministic model of the heterosexual spread of HIV
was developed (Figure 1) following established methods [29,30,31].
This type of model has been applied to many epidemiological
problems previously, including predicting the impact of anti-
retroviral therapy [32,33,34], interpreting trends in HIV preva-
lence and quantifying resource needs to tackle the epidemic
[3,35,36]. Technical details are available in the online appendix
(Text S1).
Published data from eastern Zimbabwe [8,37] were used to
inform the parameters specifying sexual behaviour, but the broad
behavioural patterns are similar to reports in other settings
[38,39,40]. In representing the observed heterogeneity in the
number of sexual partners, men and women were stratified into
risk groups that form different numbers of sexual partnerships.
Those in the higher risk groups tend to form more partnerships,
but each of these partnerships comprises fewer sex acts and
condom use is greater. Men and women form partnerships so that
it is more likely that high risk individuals form partnerships with
one another. Based on observational data from a longitudinal
study in rural Uganda [41], the course of infection is represented
by individuals progressing through several stages: acute infection
(short duration, high infectiousness), latent infection (long
duration, low infectiousness) and pre-AIDS (short duration, high
infectiousness). After pre-AIDS, a fraction of individuals develop
full-blown AIDS and die, whist others start anti-retroviral therapy
(ART) and survive for eight years with very low infectiousness. In
our model, the fraction of individuals that can start treatment
increases from 0% two years before the circumcision intervention
starts (which we take to be approximately equal to calendar year
2005) to 28% within two years (i.e. 2007) – this is typical for sub-
Saharan Africa [42]. We assume that ART coverage will plateau
at 90% by 2020. If some risk groups suffer greater AIDS-related
mortality than others, the model allows individuals to move
between groups so that the overall mean and distribution of risk in
the population is held constant.
Uncircumcised men can be circumcised in the intervention and
it is assumed that circumcised men are 60% less likely to acquire
infection each time they are exposed [19,20,21,43]. The rate at
which men are circumcised in the model is such that the eventual
level of coverage of circumcision (fraction of men circumcised) is
reached within 5 years of the intervention starting. In most
simulations no effect on male-to-female transmission is assumed,
despite some conflicting observational evidence that it may be
reduced [44,45,46,47,48]. In some simulations it is assumed that
there is short period of wound healing (2 months) immediately
following the operation, during which time most men are not
sexually active but the chance of transmission to women per sex
act may be elevated [49].
Figure 1. Flow diagram of model. The model population is divided into females, circumcised males and non-circumcised males. In each group, X0
is the number of individuals not infected, X1 is the number with acute HIV infection, X2 is the number with latent infection, X3 is the number of people
in a stage shortly prior to AIDS and X4 is the number with AIDS. The rate of progression between these stages of infection is given by s1, s2 and s3
and the rate of death for those with AIDS is s4; on average, individuals have acute infection for four months, latent infection for eight years, ‘pre-AIDS’
for twelve months and AIDS for six months. The rate of incidence among females, circumcised and non-circumcised men are represented by lf, lc and
lm respectively. The intervention is simulated by moving non-circumcised men into the group of circumcised men, at a rate which can be different
for men who are infected from those who are not or different in the different sexual activity groups (not shown): rs(t).
doi:10.1371/journal.pone.0002212.g001
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What is the likely net impact of circumcision
interventions?
In the model it is assumed that the individual circumcised man
has approximately 60% less risk of infection in each unprotected
sex act with infected women. However, the chance that a man
becomes infected will depend on his pattern of exposure to HIV.
For instance, uninfected men in sero-discordant partnerships, or
men with many sexual partners that do not use condoms, are likely
to become infected whether or not they are circumcised because
their high level of exposure will overwhelm the partial, if
substantial, protection afforded. On the other hand, circumcised
men in shorter relationships, or that regularly use condoms, will
gain a proportionately greater benefit if exposed.
Although the intervention only directly protects circumcised
men, there is an indirect benefit for women and uncircumcised
men (Figure 2). Since they are at less risk of infection, HIV
prevalence will decline among circumcised men and so, over time,
their partners (and their partners’ partners, and so on) will also be
at less risk. Then, as prevalence gradually declines among women,
the circumcised men also start to receive an indirect benefit of the
intervention. Eventually, therefore, the effectiveness of the
intervention for circumcised men actually exceeds the measured
60% biological efficacy (Figure 2).
The overall impact of circumcision interventions achieving
different levels of coverage is examined in Figure 3. The
relationship between coverage and overall impact at the
population level is strong and non-linear, meaning that marginal
increases in coverage lead to greater marginal gains in preventing
new infections. With no effect on male-to-female transmission
assumed, and 50% of men circumcised, once a new endemic
prevalence is reached after 15–20 years, incidence across men and
women is reduced by ,20% (Figure 3(a)). However, it will take
time for that full effect to be realised. Although the direct effect of
reduced incidence in the circumcised men will almost immediately
follow healing, reductions in incidence among women and
uncircumcised men rely on prevalence declining among circum-
cised men. Since median survival with HIV infection is
approximately 10 years, these indirect effect of the interventions
emerge gradually over decades. This means that cumulative
measures of the impact of the epidemic, which include infections
prior to when the full effect is exerted, provide a less substantial
indication of the effectiveness of this intervention [50]. Further-
more, over the long-term, interpreting the reduction in the
number of infections due to the intervention as ‘infections averted’
is not straight forward as faster population growth (by reducing the
effects of AIDS-related mortality and sub-fertility) can contribute
to greater numbers of infections despite the rate of incidence being
reduced.
The benefit to women is augmented if circumcised men are also
less likely to transmit the infection [46] (Figure 3(b)). In this case,
the indirect effect also emerges more quickly as women are put as
less risk of infection immediately after men are circumcised. The
strength of this additional protective effect for women depends on
the fraction of men that are circumcised, and so the relationship
between uptake of the intervention and the population-level
impact becomes steeper, and the marginal gains in extending
coverage are even greater.
How will circumcision interventions interact with existing
interventions?
Other models have indicated that with high coverage and with
circumcised men less likely to transmit infection to women then
circumcision could be used to eventually eliminate HIV [51].
However, in our analysis this does not appear to be possible,
although the intervention does make HIV infectious spread
unsustainable in some lower risk groups. A key result from early
studies of infectious disease epidemiology [52] is that several
interventions tend to operate synergistically (the specific contribu-
tion of alternative types of intervention will be determined by the
epidemiological context [53]). That is, a circumcision intervention
applied at the same time as other behavioural changes take place
will lead to a much greater impact than would be expected on the
basis of either in isolation. Figure 4 shows the incidence rate
following different kinds of intervention: a circumcision interven-
tion, a behaviour change intervention and both combined. In
combination, the two interventions can drive the HIV epidemic to
much lower levels.
Throughout southern Africa, ART programmes are being
rapidly scaled-up [1,42] and ART will interact with circumcision
interventions. ART, by itself, is not likely to lead to substantial
changes in incidence unless treatment can be initiated before
individuals reach advanced disease [34,54,55]. However, the
number of adult AIDS deaths is substantially reduced immediately
as ART programmes are scaled-up (Figure 5). The circumcision
intervention does not lead to fewer AIDS deaths in the short-term,
but in the longer-term a reduction of comparable magnitude is
achieved (Figure 5). In combination, ART and circumcision
programmes lead to great reductions in deaths and infections, in
both the short and long-term. Furthermore, interventions like
circumcision that reduce the number of infections today, will also
curb the growing demand for ART and treatment for other
opportunistic infections tomorrow, leading to considerable long-
term cost savings [36,56].
Is there the potential for perverse impacts on HIV spread
from scale up of circumcision?
Two major concerns have surrounded plans to offer circumci-
sion as an intervention – behavioural risk compensation and
Figure 2. Impact of the intervention among women (red line),
uncircumcised men (yellow line) and circumcised men (blue
line) (90% circumcision coverage achieved). The output is the
ratio of HIV incidence when the intervention is simulated relative to the
projection with no intervention. In these simulations, the operation
wound is assumed to heal instantaneously.
doi:10.1371/journal.pone.0002212.g002
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heals. Risk compensation is the phenomenon whereby those who
have taken protective steps offset the benefit with other
behavioural changes. One typical example is people using
sunscreen spending more time in the sun [57]. In the context of
male circumcision, risk compensation could include many types of
behavioural change, including increased numbers of casual
partners and less condom use. The effect of risk compensation is
complicated because circumcised men with increased risk are not
only putting themselves at more risk of infection but also their
sexual partners. In fact, the high degree of protection afforded by
circumcision means that only extreme levels of risk compensation
would lead to circumcised men being at more risk of infection than
otherwise (Figure 6). But, more moderate levels of risk compen-
sation could lead to more women becoming infected. In our
simulations, if men are ,60% less likely to use condoms with
casual partners after being circumcised there could be more
infections among women (Figure 6). Over the whole population,
however, incidence would still be reduced, by ,16%. If men
reduced condom use by 90%, then incidence among women could
increase by 40% and lead to more infections overall (Figure 6).
The chance that increased risk behaviour leads to more infections
is greater in low-level epidemics, where changes in incidence are
more sensitive to increases or decreases in risk behaviour. In these
simulations, we assume that 90% of men are circumcised in the
intervention but with lower uptake, the chance of perverse
outcomes is smaller. The inflexion shown in Figure 6 represents
lower-risk groups becoming able to support chains of transmission
when condom use is less frequent [31,58].
Another concern is that HIV transmission from infected
circumcised men might be higher in the period when the wound
is healing, if they resume sexual activity. There was a indication
(not statistically significant) that this was the case in a trial in
Uganda investigating male-to-female transmission that was
stopped early [49]. To explore the potential impact of this at the
population level, we simulated the impact of the interventions
assuming that HIV-infected men who are circumcised are twice as
likely to transmit the infection as uncircumcised men during a two-
month healing period. This is approximately equal to the relative
transmission effect observed in the trial but it is unlikely that
wounds would normally take that long to heal. We also
pessimistically assume that 40% of men resume sexually active
immediately after the operation – in the trial, less than 20% of
men resumed sexual activity sometime before the wound had fully
healed [49]. These pessimistic assumptions had very little influence
on the outcome of the intervention among women and more
widely (Figure 7). If the circumcision wound does increase
transmission and men are sexually active before the wound heals,
incidence may rise slightly during the first years of the intervention
(in our model, many men are circumcised at the same time at the
start of the intervention). However, the eventual impact of the
intervention is much the same as if it is assumed that transmission
is not increased or men do not resume sexual activity prematurely.
Discussion
Our primary finding is that circumcision alone will not be the
‘silver bullet’ that halts the HIV epidemic. A more likely scenario is
Figure 3. Projected impact of male circumcision interventions over time with different levels of coverage achieved if, (a)
circumcised men are 60% less likely to get infected but there is no effect on male-to-female transmission; and, (b) circumcised men
are 60% less likely to get infected and circumcised men are 30% less likely to transmit infection. In each panel, five epidemic projections
show circumcision interventions with 30% (red line), 45% (yellow line), 60% (blue line), 75% (brown line) or 90% (green line) of men being
circumcised. The output is the ratio of HIV incidence when the intervention is simulated relative to the projection with no intervention. Endemic HIV
prevalence before the intervention is 23%.
doi:10.1371/journal.pone.0002212.g003
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levels are achieved (Figure 3). It has previously been suggested that
the reduction in rate of HIV transmission from female-to-
circumcised-male of 60% is comparable to a vaccine delivered
to both men and women of about 37% efficacy, if all men are
circumcised [59]. Our model is good agreement with that finding,
but although acceptability of male circumcision has been reported
at promisingly high levels (circa 50% in many settings [60]),
complete coverage seems implausible. With lower coverage, a
weaker net effect is projected (Figure 3).
The indirect benefit of circumcision interventions to women
(and uncircumcised men) is mediated by reduction in HIV
prevalence among their circumcised male sexual partners (and
partners’ partners). It is slower to emerge because the long survival
time with HIV means that prevalence declines gradually.
Furthermore, since it comes via the sex partner network, its
extent is extremely difficult to predict because sexual behaviour is
multi-faceted [61], sometimes incompletely reported [62] and
because the pattern of transmission is also strongly linked to
higher-order sexual network properties [63,64]. Some simple
models may fail to capture the full extent of this indirect effect and
under-estimate the total impact of the intervention [51,65].
Similarly, analyses that measure the impact of circumcision over
only short periods (,10 years) will not quantify the full benefit of
the intervention [51]. In addition, because of the long term
consequences of the intervention it is very important that the value
of future benefits is appropriately discounted in economic analyses.
For these reasons, other studies have shown that when a short-
term time-frame is considered, quicker scale-up of services can
substantially increase the overall impact [27,66,67].
The impact of any intervention depends on the existing patterns
of risk and transmission in the population: the epidemiological
context [53]. Epidemics are sustained if the chain of transmission
(one individual infecting another) is maintained. Generally, in
communities with low risk, that chain is fragile and may be broken
by small biological or behavioural changes. If there is more risk,
the same changes have less impact because the chain is still
maintained. However, the smaller absolute number of infections
means that, in such settings, more operations may be required to
achieve the same number of infections averted. Thus, in general,
the potential proportional impact of interventions on the epidemic
is greater in low-prevalence, low-circumcision groups. The lowest
cost per infection averted, in contrast, will be achieved in higher
prevalence communities. However, since many alternative pat-
terns of risk can lead to the same endemic prevalence level, it not
possible to accurately judge the impact of the intervention using
only that information. For instance, ‘‘low’’ prevalence in a country
can signify either a core of high-risk behaviour with the rest at no
risk of infection (where the intervention could have little impact),
or a more even distribution of moderate risk throughout the
population (where the intervention could substantially contribute
to arresting transmission).
In combination with other behavioural changes, the impact of
circumcision interventions could be much greater. At the
individual-level, men that protect themselves with condoms will
get a disproportionately greater protective benefit from circumci-
Figure 4. Interaction of circumcision interventions with existing behaviour change programmes. Four epidemic projections show: (i) no
interventions, (ii) circumcision intervention with 90% coverage, (iii) a behaviour change intervention that leads to an average 30% reduction in
partner change rate and 30% increase in condom use with casual partners, (iv) both the circumcision intervention and the behaviour change
intervention. The output is HIV incidence per 100 person-years at risk (pyar). The time-scale relates to years since the circumcision intervention starts.
(Note: Unlike in other simulations, here no compensation is made for the potential effects of AIDS mortality modifying the risk distribution in the
population (see text S1 for details)).
doi:10.1371/journal.pone.0002212.g004
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will amplify the reduction in incidence. To avoid wasting resources
and a unique opportunity, circumcision programmes must be
accompanied by a renewed and vigorous focus on behaviour
change [4,8,68]. Circumcision programmes will also operate well
alongside ART programmes. The modest reduction in new
infections due to ART will be supplemented by reductions due
to circumcision. That will lead to a reduced demand for ART in
the future and, in the meantime, deaths due to AIDS will fall
substantially.
Risk compensation could dent the impact of the intervention, so
it will be especially important for safe-sex messages to be
reinforced for men being circumcised. Increased risk behaviour
could undermine derived benefits for women especially, but net
increases in incidence (among women or the population overall)
are only associated with very great increases in risk. Data from the
three randomised trials [19,20,21] and another cohort study [69]
did not find evidence for such large changes in risk following
circumcision. Being able to avoid using condoms or having more
sexual partners are not among the reported reasons for getting
circumcised [70].
The conflicting evidence on the benefits of circumcising infected
men [44,45,46,47,48], including the chance that transmission is
increased if men resume sex before the wound has healed [49],
and our modelling results leads to interesting ethical dilemma.
There is clear advantage in circumcising infected men if the
operation does reduce the chance of male-to-female transmission,
but even if it does not and transmission is greatly increased during
the healing period, the impact of the intervention for the
population is not considerably reduced. However, individual
specific women may be placed at greater risk. This has to be
considered against the potential reduction in uptake if HIV-testing
is a pre-requisite for being circumcised (necessary to avoid
circumcising any infected men). On balance, in the interests of
doing no harm, it is likely that the protection of the individual will
outweigh the protection for the population. However, our
modelling shows that this is borne out of a concern for the
individual not the population.
We have explored the sensitive of our findings to the parameters
specifying the pattern of heterosexual HIV transmission and the
biological effect of circumcision and we expect that our
conclusions will be applicable generally to the mature generalised
epidemics of southern Africa. The precise impact of interventions
will be determined by many local factors, including the
epidemiological context, the level and pattern of uptake of the
intervention, the biological effect of circumcision and the degree of
risk compensation [53]. It will be important for quantitative
projections to be tailored to the local situation and to incorporate
as much data as possible on the historic epidemic trends and
sexual behaviour. We also recognise that the impact of the
interventions will be lower if the biological effect of circumcision is
less than was found in the carefully conducted and well managed
trials [19,20,21].
It is important in modelling work to establish the influence of
model structure on the results – that is, whether the conclusions
drawn are linked to the formulation of a particular model. Our
findings are in close quantitative agreement with different types of
model that have focussed on other settings and employed
Figure 5. Comparison of circumcision interventions and ART. Four epidemic projections show (i) no interventions (red line), (ii) ART provided
to up to 90% of those in need (yellow line), (iii) circumcision intervention with 90% coverage (blue line), (iv) both the ART and the circumcision
intervention (brown line). The outputs are the annual rate of AIDS death (per 1000) and the number receiving ART (per 1000 population when the
intervention starts). The time-scale relates to years since the circumcision intervention starts. The fraction of individuals that can start treatment
increases from 0% two years before the circumcision intervention starts (which we take to be approximately equal to calendar year 2005) to 28%
within two years (i.e. 2007) – this is typical for sub-Saharan Africa [42]. We assume that ART coverage will plateau at 90% by 2020.
doi:10.1371/journal.pone.0002212.g005
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PLoS ONE | www.plosone.org 6 May 2008 | Volume 3 | Issue 5 | e2212Figure 6. The impact of risk compensation by circumcised men. Men that are circumcised in the intervention are assumed to reduce the
chance they use condom with casual partners (originally 0.6 [8,37]) by between 0 (no change) and 100% (no condom use at all with causal partners).
The output is the ratio of HIV incidence twenty years after the intervention starts among women (red line), circumcised men (yellow line), and the
population overall (blue line) when the intervention is simulated relative to the projection with no intervention. A value greater than 1 indicates that
incidence is higher with the intervention. It is assumed that 90% of men are circumcised in the intervention.
doi:10.1371/journal.pone.0002212.g006
Figure 7. The impact of the wound healing period and circumcising infected men. The projections show the impact of a circumcision
intervention with 90% of men being circumcised if it is assumed that the chance of transmission from circumcised men to women is twice as high
during the two-month healing period, and 0% of circumcised men (red line) or 40% of men (yellow line) are sexually active whilst the wound heals
(yellow line). The output is the ratio of HIV incidence when the intervention is simulated relative to the projection with no intervention.
doi:10.1371/journal.pone.0002212.g007
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aim to identify ways in which the impact of the intervention could
be maximised, quantify uncertainty in projections and explore
different techniques for predicting the impact of interventions,
from micro-simulation to tractable analysis [71]. Mathematical
modelling must build upon the gold-standard evidence from the
randomised controlled trials to provide both qualitative under-
standing and detailed quantitative predictions to support the
decision-making processes that are now underway.
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